- Country: Brazil
- Summary: Price Registration for Future and Eventual Acquisition of Basic, Injectable and Complementary Medicines, Meeting the Demands of Municipalities Associated with Cisalv.
- BRT Ref No: 99177584
- Deadline: 08 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90008/2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Price Registration for future and eventual acquisition of basic, injectable and complementary medicines meeting the demands of municipalities associated with CISALV.
UASG Code: 927658
Notice from: 03/21/2024 at 08:00 to 12:00 pm and from 1:00 pm to 5:00 pm
Entr19981d172c851bd4e8a1788d5726c2d3time of the Proposal: from 03/21/2024 at 08:00
8-HYDROXYQUINOLINE BORATE, PRESENTATION ASSOCIATED WITH TRIETHANOLAMINE, CONCENTRATION 0.4MG 140MG/ML, INDICATION ENT SOLUTION
Quantity: 800
ACEBROPHYLLINE, CONCENTRATION 10 MG/ML , PHARMACEUTICAL FORM SYRUP
Quantity: 800
ACEBROPHYLLINE, CONCENTR19981d172c851bd4e8a1788d5726c2d3ACTION 5 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 800
ACETYLCYSTEINE, DOSAGE 20 MG/ML, INDICATION SYRUP
Quantity: 5000
ACETYLCYSTEINE, CONCENTRATION 40 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 5000
ACETYLSALICYLIC ACID, DO SAGEM 100 MG, BUFFERED USE TYPE
Quantity: 108000
ACETYL ACID19981d172c851bd4e8a1788d5726c2d3SALICYLIC, DOSAGE 100 MG, BUFFERED USE TYPE
Quantity: 12000
ASCORBIC ACID, DOSAGE 1 G, EFFERVESCENT TABLET USE TYPE
Quantity: 8000
ASCORBIC ACID, DOSAGE 100 MG/ML, INJECTABLE USE TYPE
Quantity: 800
T ACID RANEXAMIC, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity19981d172c851bd4e8a1788d5726c2d3ade: 600
ZOLEDRONIC ACID, CONCENTRATION 4 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 200
AMBROXOL, HYCLORYDRATE SALT COMPOSITION, CONCENTRATION 3 MG/ML, PHARMACEUTICAL SYRUP FORM
Quantity: 3500
AMBROXOL, CL SALT COMPOSITION OHYDRATE, CONCENTRATION 6 MG/ML, PHARMACEUTICAL FORM SYRUP
Quan19981d172c851bd4e8a1788d5726c2d3Quantity: 3500
AMICACIN SULFATE, DOSAGE 250 MG/ML, INJECTION SOLUTION INJECTABLE
Quantity: 1000
AMILORIDE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH CHLORTHALIDONE, CONCENTRATION 5 MG 25 MG
Quantity: 4000
AMOXICILLIN, ACTIVE PRINCIPLE ASSOCIATED WITH CLAV POTASSIUM ULANATE, CONCENTRATION 1G 200MG, APRES19981d172c851bd4e8a1788d5726c2d3INJECTABLE ENTATION
Quantity: 800
ANLODIPINE BESYLATE, ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration for Future and Eventual Acquisition of Basic, Injectable and Complementary Medicines, Meeting the Demands of Municipalities Associated with Cisalv. - Brazil Tender
The INTERMUNICIPAL HEALTH CONSORTIUM ALTO DAS VERTENTES/MG, a Government sector organization in Brazil, has announced a new tender for Price Registration for Future and Eventual Acquisition of Basic, Injectable and Complementary Medicines, Meeting the Demands of Municipalities Associated with Cisalv.. This tender is published on BrazilTenders under BRT Ref No: 99177584 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-08.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
